Evidence map›Paper›PMID 34992128›Full record

ArticleAJNR. American journal of neuroradiology2022

Automated Color-Coding of Lesion Changes in Contrast-Enhanced 3D T1-Weighted Sequences for MRI Follow-up of Brain Metastases.

D Zopfs, K Laukamp, R Reimer, N Grosse Hokamp, C Kabbasch, J Borggrefe, L Pennig, A C Bunck, M Schlamann, S Lennartz

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Automatically tracking brain metastases after stereotactic radiosurgery.Physics and imaging in radiation oncology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

D ZopfsFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany David.zopfs@uk-koeln.de.ORCID 0000-0001-9978-7453
K LaukampFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-5600-5914
R ReimerFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-5900-7181
N Grosse HokampFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0001-7928-0487
C KabbaschFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0003-3712-2258
J BorggrefeDepartment of Radiology (J.B.), Neuroradiology and Nuclear Medicine, Johannes Wesling University Hospital, Ruhr University Bochum, Bochum, Germany.ORCID 0000-0003-2908-7560
L PennigFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-6606-9313
A C BunckFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0003-0986-0042
M SchlamannFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-7734-611X
S LennartzFrom the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-3254-4809

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMR imaging is the technique of choice for follow-up of patients with brain metastases, yet the radiologic assessment is often tedious and error-prone, especially in examinations with multiple metastases or subtle changes. This study aimed to determine whether using automated color-coding improves the radiologic assessment of brain metastases compared with conventional reading. MATERIALS AND

methodsOne hundred twenty-one pairs of follow-up examinations of patients with brain metastases were assessed. Two radiologists determined the presence of progression, regression, mixed changes, or stable disease between the follow-up examinations and indicated subjective diagnostic certainty regarding their decisions in a conventional reading and a second reading using automated color-coding after an interval of 8 weeks.

resultsThe rate of correctly classified diagnoses was higher (91.3%, 221/242, versus 74.0%, 179/242,

conclusionsCompared with the conventional reading, automated color-coding of lesion changes in follow-up examinations of patients with brain metastases significantly increased the rate of correct diagnoses and resulted in higher diagnostic certainty.

Indexed as

Brain NeoplasmsMagnetic Resonance ImagingContrast MediaFollow-Up StudiesHumansRetrospective StudiesContrast Media

Identifiers

PMID34992128
PMCPMC8985679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.